Houlihan Lokey, Inc. (NYSE:HLI) Declares $0.57 Quarterly Dividend

Houlihan Lokey, Inc. (NYSE:HLI) declared a quarterly dividend on Wednesday, October 30th,Zacks Dividends reports. Stockholders of record on Monday, December 2nd will be given a dividend of 0.57 per share by the financial services provider on Sunday, December 15th. This represents a $2.28 annualized dividend and a dividend yield of 1.20%. The ex-dividend date of this dividend is Monday, December 2nd.

Houlihan Lokey has raised its dividend by an average of 19.4% annually over the last three years. Houlihan Lokey has a payout ratio of 33.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Houlihan Lokey to earn $7.04 per share next year, which means the company should continue to be able to cover its $2.28 annual dividend with an expected future payout ratio of 32.4%.

Houlihan Lokey Stock Up 1.0 %

HLI stock opened at $189.29 on Friday. The stock has a market capitalization of $13.16 billion, a PE ratio of 38.71 and a beta of 0.65. Houlihan Lokey has a 52 week low of $105.34 and a 52 week high of $192.10. The firm has a 50 day moving average of $172.84 and a 200 day moving average of $152.98.

Houlihan Lokey (NYSE:HLI) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.46 EPS for the quarter, topping the consensus estimate of $1.31 by $0.15. The business had revenue of $574.96 million during the quarter, compared to the consensus estimate of $537.93 million. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. The business’s revenue for the quarter was up 23.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.11 earnings per share. On average, equities research analysts expect that Houlihan Lokey will post 5.79 earnings per share for the current year.

Analysts Set New Price Targets

HLI has been the topic of several research analyst reports. StockNews.com downgraded Houlihan Lokey from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Morgan Stanley upped their target price on Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a research report on Monday, September 23rd. Wells Fargo & Company began coverage on shares of Houlihan Lokey in a report on Thursday, September 12th. They issued an “underweight” rating and a $149.00 price target on the stock. Finally, UBS Group lifted their price objective on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a research note on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $157.00.

Insider Buying and Selling

In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total value of $155,290.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gillian Beth Zucker sold 200 shares of the stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $168.08, for a total transaction of $33,616.00. Following the sale, the director now directly owns 6,601 shares in the company, valued at approximately $1,109,496.08. The trade was a 2.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,400 shares of company stock valued at $219,362 over the last ninety days. Company insiders own 23.68% of the company’s stock.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.